High‐concentration (8%) capsaicin patch vs control patch (0.4%)
Serious adverse events · adults with postherpetic neuralgia
1 finding from 1 review
- Topical capsaicin (high concentration) for chronic neuropathic pain in adults 2017 · Cochrane Headline outcomes onlyno estimate extracted7 studies · 1993 participantsModerate